The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved Medications used to treat Opioid use disorder-methadone, naltrexone, and buprenorphine-and the other strategies and Services needed to support recovery..
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved Medications used to treat Opioid use disorder-methadone, naltrexone, and buprenorphine-and the other strategies and Services needed to support recovery.